Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Free Paper Session 16: Vascular Diseases & Diabetic Retinopathy IV

11:00 - 12:30 | 22 September | Room: Room C4.

Back to Previous

11:00The management of neovascular retinal vein occlusions in post intravitreal treatment patients
R. Patel United Kingdom
11:06Correlation between polyp size and presence of blood flow signals in polyps by optical coherence tomography angiography for polypoidal choroidal vasculopathy
T. Qian China
11:12Association of peripheral blood proinflammatory factors with intravitreal corticosteroid treatment in persistent diabetic macular edema
P. Brito Portugal
11:18Oct biomarkers in refractory DME Boon or bane ?
S. Vasudevan India
11:24Comparison of the outcomes of two different intravitreal treatment protocols in treatmentnaive phakic eyes with macular vein occlusion
T. Ozturk Turkey
11:30Influence of arterial hypertension on choroidal thinning in type 2 diabetic patients
C. Isanta Otal Spain
11:36Relationship between mean haemoglobin A1c levels for 5 years and diabetic retinopathy and choroidopathy
O. Ruiz Moreno Spain
11:42Vascular retinopathy screening in pregnancy – results from a crosssectional study
R. Marques Portugal
11:48Evaluation of markers of outcome in diabetic macular edema
A. Campos Portugal
11:54Visual outcomes after intravitreal ranibizumab for macular edema secondary to juvenile central retinal vein occlusion
F. Romano Italy
12:00Evolution of baseline characteristics of treatmentnaïve patients with diabetic macular edema over 4 years of enrollment into the LUMINOUS study
P. Mitchell Australia
12:06Randomized clinical trial of intravitreal bevacizumab versus intravitreal bevacizumab combined with losartan in the treatment of diabetic macular edema
F. Ghassemi Iran, Islamic Republic of
12:12Microaneurysm turnover is a predictor of diabetic retinopathy progression
M. Ribeiro Portugal
12:18Evaluation of the symmetry of functional response to Intravitreal Aflibercept treatment for bilateral diabetic macular oedema: Realworld outcomes
D. Bhatia United Kingdom
Back to Previous

Sign up to EURETINA

© EURETINA All rights reserved
Loading please wait